Process for the preparation of hmg-coa reductase inhibitors intermediates
CA 1319700 C · Owner: Merck & Co. Inc. · Inventors: Volante, Ralph P.; Shinkai, Ichiro; Lynch, Joseph E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A novel process for the preparation of an intermediate ester in the synthesis of hypercholesterolemic compounds of the HMG-CoA reductase type of the following general formula (1): (1), involving an enantioselective aldol condensation is disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted June 29, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended June 29, 2010.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.